U.S.C. homeSearch U.S. Code
U.S. CodeTitle 21Chapter 9— Federal Food, Drug, And Cosmetic ActSubchapter X— Miscellaneous

21 U.S.C. § 391 (2026)

Separability clause

Edition and currency
U.S. Code current through Pub. L. 119-102 (OLRC release point). The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTU.S. Code current through Pub. L. 119-102 (OLRC release point) cited 2001–2025 6citing cases
At a glance

Courts have cited this section in 6 opinions since 2001, 1 of them in the last five years.

If any provision of this chapter is declared unconstitutional, or the applicability thereof to any person or circumstances is held invalid, the constitutionality of the remainder of the chapter and the applicability thereof to other persons and circumstances shall not be affected thereby.

(June 25, 1938, ch. 675, § 1001, formerly § 901, 52 Stat. 1059; renumbered § 1001, Pub. L. 111–31, div. A, title I, § 101(b)(2), June 22, 2009, 123 Stat. 1784.)
The 6 cases that cite 21 U.S.C. § 391 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENWimbush ex rel. Est. of Buchanan v. Wyeth, 619 F.3d 632 (6th Cir. 2010).
cites § 391 2×cited by 78 cases
Where it cites § 391
“The district court found that Buchanan's pre-approval negligence claims were preempted by the Federal Food, Drug, and Cosmetic Act (FDCA), 21 U.S.C. § 391 et seq., which is enforced by the FDA, 21 U.”
The case’s holding
FDA approval does not automatically preempt state law negligence claims regarding a manufacturer's conduct in bringing a drug to market prior to approval.
Later courts cite it for
“when a motion for summary judgment is properly made and supported and the nonmoving party fails to respond with a showing sufficient to establish an essential element of its case, summary judgment is appropriate.” · 7 citing courts
2
GREENMed. Ctr. Pharmacy v. Mukasey, 536 F.3d 383 (5th Cir. 2008).
cites § 391 1×cited by 34 cases
Where it cites § 391
“21 U.S.C. § 391 . In Koog v. United States, 79 F.”
The case’s holding
Compounded drugs are new drugs under the FDCA but are exempt from approval only when they meet the specific statutory conditions for pharmacy compounding.
Later courts cite it for
“construing the fdca to give the fda authority over compounding would thus not necessarily 'lead to a result so bizarre that congress could not have intended it.” · 1 citing court
3
GREENMed. Ctr. Pharmacy v. Gonzales, 451 F. Supp. 2d 854 (W.D. Tex. 2006).
cites § 391 1×cited by 5 cases
Where it cites § 391
“” See 21 U.S.C. § 391 . The existence of this clause creates a presumption that Congress intended the rest of a *863 provision contained within the Act would remain valid if a portion was declared unconstitutional.”
Later courts cite it for
“implicitly exempt from the new drug approval process.” · 2 citing courts
4
GREENLongs ex rel. Est. of Buchanan v. Wyeth, 536 F. Supp. 2d 843 (N.D. Ohio 2008).
cites § 391 1×cited by 4 cases
Where it cites § 391
“MOTION FOR PARTIAL SUMMARY JUDGMENT BASED ON FEDERAL PREEMPTION Defendants argue that Plaintiffs claims are preempted by the Federal Food, Drug, and Cosmetic Act (“FDCA” or the “Act”), 21 U.S.C. § 391 et seqwhich is enforced by the Food and Drug Administration (“FDA”), 21 U.”
5
GREENW. States Med. Ctr. v. Shalala, 238 F.3d 1090 (9th Cir. 2001).
cites § 391 1×cited by 8 cases
Where it cites § 391
“…remainder of the Act and the applicability thereof to other persons and circumstances shall not be affected thereby. 21 U.S.C. § 391 .”
6
NO FLAG(HC) Papazian v. B.M. Trate, No. 1:24-cv-00392 (E.D. Cal. Aug. 29, 2025).
cites § 391 1×cited by 0 casesunknown
Where it cites § 391
“BACKGROUND 8 Petitioner is currently serving a 292-month federal prison sentence for his 2019 conviction 9 out of the United States District Court for the District of Nebraska for conspiracy to distribute 50 10 grams or more of actual methamphetamine in violation of 21 U.S.C. §§…”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
200120132025

One bar per year. Tallest: 2 cases in 2008. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
5th Cir.16th Cir.19th Cir.1E.D. Cal.1N.D. Ohio1W.D. Tex.1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments
(June 25, 1938, ch. 675, § 1001, formerly § 901, 52 Stat. 1059; renumbered § 1001, Pub. L. 111–31, div. A, title I, § 101(b)(2), June 22, 2009, 123 Stat. 1784.)
Versions

Edition shown: U.S. Code current through Pub. L. 119-102 (OLRC release point). Syfert holds no earlier or later version of this section.

U.S.C. Home  |  Search U.S. Code  |  Search cases for this section  |  syfert.com